 |
ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123 |
|---|---|
| Trade Name | not avaiable |
| Orphan Indication | |
| USA Market Approval | USA |
| USA Designation Date | 2018-01-04 00:00:00 |
| Sponsor | iCell Gene Therapeutics 25 Health Sciences Drive, Suite 118 Stony Brook, New York, 11793 |
